Authors:
WALLIS DE
LEWIS BE
MESSMORE H
WEHRMACHER WH
Citation: De. Wallis et al., HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS SYNDROME, Clinical and applied thrombosis/hemostasis, 4(3), 1998, pp. 160-163
Authors:
FAREED D
FAREED J
YANG L
HOPPENSTEADT D
JESKE W
HAAS S
MESSMORE H
Citation: D. Fareed et al., HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES, The FASEB journal, 12(4), 1998, pp. 1117-1117
Authors:
FAREED D
FAREED J
YANG L
HOPPENSTEADT D
JESKE W
HAAS S
MESSMORE H
Citation: D. Fareed et al., HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 24-24
Citation: Wh. Wehrmacher et H. Messmore, THROMBOPHILIA - CONSIDER HOMOCYSTEINE TOO, Clinical and applied thrombosis/hemostasis, 3(2), 1997, pp. 147-148
Authors:
AHSAN A
AHMAD S
IQBAL O
SCHWARZ R
KNAPPENBERGER G
JOFFRION J
BECKER JC
MESSMORE H
Citation: A. Ahsan et al., COMPARATIVE-STUDIES ON THE BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIESOF A MAJOR METABOLITE OF ARGATROBAN (M1) - POTENTIAL CLINICAL IMPLICATIONS, Thrombosis and haemostasis, 1997, pp. 370-370
Authors:
AHMAD S
AHSAN A
GEORGE M
WYMA D
SCHWARZ R
KNAPPENBERGER G
JOFFRION J
BECKER JC
MESSMORE H
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN IN PATIENTS UNDERGOING ANTICOAGULANT TREATMENT AND CORONARY ANGIOPLASTY, Thrombosis and haemostasis, 1997, pp. 2412-2412
Authors:
MESSMORE H
ORFEI E
COYNE E
FRESCO R
FAREED J
Citation: H. Messmore et al., HYPERVISCOSITY AND COAGULOPATHY DUE TO CIRCULATING HYALURONIC-ACID INA PATIENT WITH HEPATOMA, Blood, 90(10), 1997, pp. 3190-3190
Authors:
CHAMBERLIN JR
LEWIS B
LEYA F
WALLIS D
MESSMORE H
HOPPENSTEADT D
WALENGA JM
MORAN S
FAREED J
MCKIERNAN T
Citation: Jr. Chamberlin et al., SUCCESSFUL TREATMENT OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA AND THROMBOSIS USING HIRULOG, Canadian journal of cardiology, 11(6), 1995, pp. 511-514
Authors:
FABBRINI N
HEMPHILL S
GODWIN J
MESSMORE H
BALBALE S
LAY M
PANZA L
CROSBY T
DILLON R
BRACE L
Citation: N. Fabbrini et al., PERFORMANCE-CHARACTERISTICS OF THE MORE RESPONSIVE THROMBOPLASTIN REAGENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1113-1113
Authors:
FABBRINI N
MESSMORE H
BRACE L
HEMPHILL S
BALBALE S
LAY M
PANZA L
CROSBY T
DILLON R
GODWIN J
CHEIFEC G
Citation: N. Fabbrini et al., COMPARISON OF THE PERFORMANCE-CHARACTERISTICS OF 14 COMMERCIAL PARTIAL THROMBOPLASTIN REAGENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1238-1238
Authors:
COYNE E
MESSMORE H
WALENGA JM
HOPPENSTEADT D
FARID S
WEHRMACHER W
BERMES EW
Citation: E. Coyne et al., FISH SKIN GLYCOSAMINOGLYCANS - A SOURCE FOR HIGHLY-ACTIVE HEAVILY SULFATED CHONDROITIN SULFATES, Thrombosis and haemostasis, 73(6), 1995, pp. 1351-1351
Authors:
FABBRINI N
HEMPHILL S
BALBALE S
MESSMORE H
BRACE L
LAY M
PANZA L
CROSBY T
DILLON R
Citation: N. Fabbrini et al., PROTHROMBIN TIME - PERFORMANCE-CHARACTERISTICS OF THE MORE SENSITIVE THROMBOPLASTIN REAGENTS, Blood, 84(10), 1994, pp. 10000200-10000200
Authors:
MESSMORE H
FABBRINI N
FARID S
MORGAN J
MCLEAN K
YUEN B
FAREED J
BHOOPALAM N
HOPPENSTEADT D
Citation: H. Messmore et al., UNIQUE CIRCULATING ANTICOAGULANT IN A MYELOMA PATIENT WITH PROTEIN-C DEFICIENCY AND VENOUS THROMBOSIS, Blood, 84(10), 1994, pp. 10000680-10000680
Authors:
FABBRINI N
KOZA M
HOPPENSTEADT D
WALENGA JM
FASANELLA A
MESSMORE H
FAREED J
Citation: N. Fabbrini et al., VALIDATION OF HEPTEST AND A MODIFIED (HEPTEST-HI) IN MONITORING THERAPEUTIC ANTICOAGULATION BY HEPARINS, Thrombosis and haemostasis, 69(6), 1993, pp. 1109-1109
Authors:
BACHER P
MARKWARDT F
MESSMORE H
FAREED J
WALENGA J
HOPPENSTEADT D
OFOSU F
FINK E
AMIRAL J
FENTON J
SAWYER R
MARAGANORE J
BREDDIN HK
LEYA F
HUBBARD T
STEMBERGER A
KAISER B
ROSENKRANZ B
KU C
BUTTI A
PIFARRE R
Citation: P. Bacher et al., MEDICAL AND SURGICAL USES OF RECOMBINANT HIRUDIN - AN INTERNATIONAL DISCUSSION FORUM MUNICH, GERMANY, JUNG 26, 1991, Seminars in thrombosis and hemostasis, 19, 1993, pp. 210-216
Citation: H. Messmore et al., COMPARISON OF THE HEPTEST(R), HEPTEST HI(R) WITH THE ACTIVATED PARTIAL THROMBOPLASTIN TIME TO MONITOR LOW-MOLECULAR-WEIGHT HEPARIN-THERAPY, Blood, 82(10), 1993, pp. 10000597-10000597
Authors:
GODWIN JE
HOPENSTEADT D
BLAKEMORE C
FARID S
FAREED J
MESSMORE H
Citation: Je. Godwin et al., RECOMBINANT TISSUE FACTOR AS A REAGENT FOR THE DETECTION OF THE LUPUSANTICOAGULANT, Blood, 82(10), 1993, pp. 10000617-10000617